Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Arch Dis Child Fetal Neonatal Ed ; 102(3): F244-F250, 2017 May.
Article in English | MEDLINE | ID: mdl-27737909

ABSTRACT

BACKGROUND: Antibiotic resistance is a worldwide problem. We describe 25 years of responsible antibiotic use in a tertiary neonatal unit. METHODS: Data on neonatal infections and antibiotic use were collected prospectively from 1990 to 2014 at a single tertiary Sydney neonatal intensive care unit attached to a maternity unit. There are approximately 5500 deliveries and 900 nursery admissions per year. RESULTS: The mean annual rate of late-onset sepsis was 1.64 episodes per 100 admissions. The mean number of late-onset sepsis episodes per admission to the neonatal unit decreased by 4.0% per year (95% CI 2.6% to 5.4%; p<0.0001) and occurred particularly in infants born weighing <1500 g. No infants with negative cultures relapsed with sepsis when antibiotics were stopped after 48-72 hours. Antibiotic use decreased with time. The proportion of colonising methicillin-resistant Staphylococcus aureus isolates decreased by 7.4% per year (95% CI 0.2% to 14.1%; p=0.043). The proportion of colonising Gram-negative bacilli isolates resistant to either third-generation cephalosporins or gentamicin increased by 2.9% per year (95% CI 1.0% to 4.9%; p=0.0035). Most were cephalosporin-resistant; gentamicin resistance was rare. An average of one baby per year died from late-onset sepsis, the rate not varying significantly over time. The mortality from episodes of late-onset sepsis was 25 of 332 (7.5%). CONCLUSION: Stopping antibiotics after 2-3 days if neonatal systemic cultures are negative is safe. However, it does not prevent the emergence of cephalosporin-resistant Gram-negative organisms.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Bacterial Infections/drug therapy , Drug Resistance, Microbial , Intensive Care Units, Neonatal/statistics & numerical data , Anti-Bacterial Agents/therapeutic use , Bacterial Infections/epidemiology , Drug Administration Schedule , Drug Utilization/statistics & numerical data , Drug Utilization/trends , Humans , Infant, Newborn , Intensive Care Units, Neonatal/trends , Methicillin-Resistant Staphylococcus aureus/isolation & purification , New South Wales/epidemiology , Prospective Studies , Sepsis/drug therapy , Sepsis/epidemiology , Staphylococcal Infections/drug therapy , Staphylococcal Infections/epidemiology
2.
Dev Neurorehabil ; 15(3): 171-7, 2012.
Article in English | MEDLINE | ID: mdl-22582847

ABSTRACT

OBJECTIVE: To examine the inter-rater reliability of The King's Outcome Scale for Childhood Head Injury (KOSCHI) with clinicians of varying experience in paediatric traumatic brain injury (TBI); and to examine change in outcome during long-term follow-up of children following traumatic brain injury (TBI) using KOSCHI. METHOD: Retrospective assessment of detailed clinic reports of 97 children followed-up by a tertiary specialist paediatric brain injury service. Investigators were blinded to each other's scores. RESULTS: Inter-rater reliability was substantial (weighted kappa 0.71) and similar for investigators of varying experience. KOSCHI outcome was strongly associated with markers of injury severity (p = 0.028). In longitudinal follow-up, KOSCHI score worsened in 7 (23%) children who were injured under 8 years but in no older children (p = 0.02). CONCLUSION: KOSCHI has high inter-rater reliability for investigators of different experience. Long-term KOSCHI outcome is associated with injury severity. Some young children may develop worse disability over time.


Subject(s)
Brain Injuries/diagnosis , Craniocerebral Trauma/diagnosis , Adolescent , Child , Child, Preschool , Female , Follow-Up Studies , Glasgow Outcome Scale , Humans , Injury Severity Score , Male , Reproducibility of Results , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL